Impact of strenuous exercise on the release of cardiac biomarkers? - - PowerPoint PPT Presentation

impact of strenuous exercise on the release of cardiac
SMART_READER_LITE
LIVE PREVIEW

Impact of strenuous exercise on the release of cardiac biomarkers? - - PowerPoint PPT Presentation

Impact of strenuous exercise on the release of cardiac biomarkers? LE GOFF Caroline PhD Student Clinical Biologist University Hospital of Lige Belgium Background Cardiovascular diseases (CVD) represent the leading cause of death in


slide-1
SLIDE 1

LE GOFF Caroline PhD Student Clinical Biologist University Hospital of Liège Belgium

Impact of strenuous exercise on the release of cardiac biomarkers?

slide-2
SLIDE 2

Background

  • Cardiovascular diseases (CVD) represent the leading

cause of death in the United States, as well as in numerous developed countries, ahead of cancers and accidents

  • The risk of cardiac events or sudden death after a

vigorous physical efgort has been described

  • The death incidence linked to physical exercise is more

important among elderly people than among younger

  • nes and among persons who do not practise regular

physical activity

  • These undesirable events occur following a coronary
slide-3
SLIDE 3

Background

  • Cardiac troponins (T and I)(cTnT and cTnI)

are considered as the best biomarkers for detection of myocardial cell injury and NT-proBNP as the best for the cardiac insuffjciency.

  • In this study, cTnT was measured by new

commercially available high-sensitive methods in subjects undergoing the Maasmarathon.

slide-4
SLIDE 4

Aim

  • To compare cTnT and NT-proBNP levels

before and after the stress test, in runners.

slide-5
SLIDE 5

Materials and methods

  • 28 subjects (26 ♂, 42.5±11yo)  race of

42.195 kilometers between Visé (Belgium) and Maastricht (The Netherlands).

  • Performance = 4h06±35 min
  • Blood samples

– before =T0 – just after=T1 the race – 3 hours after=T3

slide-6
SLIDE 6

Materials and methods

  • cTnT concentrations were measured by high

sensitive methods (hsTnT, Roche Diagnostics)

  • n heparin plasma.
  • NT-proBNP level was also determined with the

kit from Roche Diagnostics on heparin plasma.

  • The protocol was approved by the ethic

committee of the University of Liège (Belgium). All subjects gave their informed consent.

slide-7
SLIDE 7

Results

slide-8
SLIDE 8

Results

p<0.0001 ns p<0.0001

Decision limit 0.014 µg/L

slide-9
SLIDE 9

Results

p<0.0001 p<0.0001

ns

Decision limit 103 pg/ml

slide-10
SLIDE 10

Results

Comparison between different races for TnThs

slide-11
SLIDE 11

Results

Comparison between different races for NT-proBNP

slide-12
SLIDE 12

Conclusions

  • Measurement of cardiac troponins by high

sensitive methods enables the detection

  • f a significant release of biomarkers

from the heart during exercise.

  • The value of NT-proBNP are also

significant but less than TnThs.

  • We think that the TnThs could be an

interesting tool in the future to help sport medicine to detect risk of developing a

slide-13
SLIDE 13

Conclusions

  • Measurement of cardiac troponins by high

sensitive methods enables the detection

  • f a significant release of biomarkers

from the heart during exercise.

  • The value of NT-proBNP are also

significant but less than TnThs.

  • We think that the TnThs could be an

interesting tool in the future to help sport medicine to detect risk of developing a

slide-14
SLIDE 14

Thank you very much for your

slide-15
SLIDE 15

16